In human colon cancer HT-29 and LoVo cells, genistein could stimulate apoptosis by downregulating the NF-κB pathway and Bcl-2 while upregulating Bax; therefore, it provides the basis for genistein clinical application in colon cancer cases [141]. Here, BAX is linked to malignant colon neoplasm.